Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the potential effects of multiple doses of
rifampin and clarithromycin on the single dose pharmacokinetics (PK) of the deflazacort
active metabolite (21 desacetyl-DFZ) in healthy adult subjects.